Sensome, the pioneer of microsensing technology for real-time, in situ tissue analysis, today announced the publication of a ...

AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Proteomic-based ...

A new study unveils a method to non-invasively monitor cell spatiotemporal dynamics involved in cancer progression in a ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

Explore how artificial intelligence is changing cancer care and what it means for the future of precision oncology.

Paper Published in Science Advances Unveils Results of Multi-Year Collaboration between Sensome, École Polytechnique and French National Center for Scientific Research (CNRS) Sensome, the pioneer ...

MUNGKHOOD STUDIO // ShutterstockHow artificial intelligence is transforming medical imagingA decade ago, deep learning prototypes wowed conferences but rarely touched patients. By June 2025, 777 ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted cancer therapies using its ...

UNSW Sydney scientists are working to develop Australia's first commercialised lipid-based blood test for breast cancer detection powered by ...